Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 13th March 2020
Qumulo

Qumulo Offers Free Cloud Software to Help Medical and Healthcare Research Organisations Fight the COVID-19 Outbreak



London, UK – 13th March, 2020 – Qumulo today announced it is offering its cloud-native file software, for free, to public and private sector medical and healthcare research organisations that are working to minimize the spread and impact of the COVID-19 virus.

Effective immediately, Qumulo is making its software in the public cloud available free of charge through July 2020 to organisations combating the COVID-19 outbreak.

Researchers and clinicians are working day and night to learn more about COVID-19. Organisations are building tools to track its spread and to develop containment and eradication measures, including the development of a vaccination. The public cloud is critical to enabling actionable results, fast.

“Research and healthcare organisations across the world are working tirelessly to find answers and collaborate faster in their COVID-19 vaccine mission,” said Matt McIlwain, chairman of the board of trustees of the Fred Hutchinson Cancer Research Center and managing partner at Madrona Venture Group. “It will be through the work of these professionals globally, sharing and analysing all available data in the cloud, that a cure for COVID-19 will be discovered.”

At a time when every minute matters for the public health of the global community, research organisations need the ability to launch workloads with large amounts of compute power to analyse large data sets using their trusted applications for research. With Qumulo’s cloud-native file and data services, organizations can do that in the cloud to capture, process, analyse and share data with researchers distributed across geographies. Qumulo’s software works seamlessly with the applications medical and healthcare researchers have been using for decades, as well as artificial intelligence and analytics services more recently developed in the cloud.

“Using Qumulo’s software to manage and understand petabytes of data real-time, medical and research organisations around the world can work together and leverage the power of the cloud and hybrid environments to fight COVID-19,” said Bill Richter, president and CEO of Qumulo. “This virus requires every organisation that can make a difference to do so right now, and band together to solve this problem with all available technology resources and the smartest minds on the planet collaborating seamlessly.”

Please visit qumulo.com/cloudfileforcovid to register your organisation for the use of Qumulo’s file software in the cloud, which will be deployable through the Amazon Web Services and Google Cloud Marketplaces.

Resources
Qumulo Hybrid File Software
File Storage Built for the Hybrid Cloud
Try Qumulo’s Hybrid Cloud File Storage

About Qumulo, Inc.
Qumulo is the leader in enterprise-proven hybrid cloud file storage, providing real-time visibility, scale and control of your data across on-prem and the cloud. Qumulo’s real-time analytics help save time and money while increasing performance. Built to scale across the data centre and cloud, Qumulo’s software-defined file system enables programmatic configuration and management of usage, capacity and performance. Qumulo has completely redefined customer success by continuously delighting customers with new capabilities, 100 percent-usable capacity and direct access to experts. For more information, visit www.qumulo.com.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2004 Innovations in Pharmaceutical Technology | Terms and Conditions | joel@samedanltd.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |